Key facts
- It has raised $3.3M; the latest was Later Stage VC in Oct 2025.
- Notable investors include Alumni Ventures, Creative Destruction Lab, Joyance Partners, BoxOne Ventures, Fusion Fund — 23 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Nimble Science
- ·The full record, as it builds
Funding rounds
No funding rounds for Nimble Science are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nimble Science
Operator of a health technology company delivering precision datasets from the gastrointestinal tract, leveraging a capsule sampling technology, and creating a paradigm shift. The company's product enables passive sampling of small bowel luminal fluid to leverage intestinal data to provide insights, enabling healthcare providers with direct sampling and analysis of targeted regions of the gastrointestinal tract.
- Sector
- Healthcare
- HQ
- Calgary, Canada
- Founded
- 2018
- Employees
- 25
- Website
- nimblesci.com/
- Ownership
- Privately Held (backing)
Nimble Science doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nimble Science shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nimble Science in its N-PORT filings yet. We sweep new filings monthly.